- Home
- VRSN vs GH Comparison
VRSN vs GH Comparison
Compare VRSN & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRSN | GH |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 22.9B |
| IPO Year | 1997 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VRSN | GH |
|---|---|---|
| Price | $278.69 | $176.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 19 |
| Target Price | ★ $317.67 | $119.79 |
| AVG Volume (30 Days) | 626.1K | ★ 1.7M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ 6.24 | N/A |
| Revenue | ★ $1,656,600,000.00 | $982,021,000.00 |
| Revenue This Year | $6.78 | $33.30 |
| Revenue Next Year | $5.37 | $28.27 |
| P/E Ratio | $45.20 | ★ N/A |
| Revenue Growth | 6.37 | ★ 32.88 |
| 52 Week Low | $209.34 | $60.46 |
| 52 Week High | $312.48 | $183.51 |
Technical Indicators
Market Signals| Indicator | VRSN | GH |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 57.52 |
| Support Level | $271.10 | $153.88 |
| Resistance Level | $280.61 | $183.51 |
| Average True Range (ATR) | 6.83 | 7.66 |
| MACD | -2.46 | 0.22 |
| Stochastic Oscillator | 8.08 | 73.14 |
Price Performance
Historical ComparisonAbout VRSN VeriSign Inc.
Verisign is an operator of critical infrastructure within the domain name system, or DNS. As the registry for some of the world's most popular TLDs, .com and .net, Verisign directs DNS resolvers to the appropriate registry where IP addresses are stored. Verisign's control over its TLDs is regulated by ICANN and the NTIA and are subject to contract renewal every six years. The company generates revenue through annual subscriptions allowing customers to use .com and .net as their TLD of choice for their respective websites.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.